Treatment Toxicities
Cross-source consensus on Treatment Toxicities from 1 sources and 5 claims.
1 sources · 5 claims
Risks & contraindications
Other
Highlighted claims
- Breast cancer-related lymphoedema is defined using arm circumference or volume differences confirmed clinically. — PERSEVERE: longitudinal assessment of quality of life and treatment toxicities in Chinese breast cancer patients – a multicentre cohort study protocol
- Cardiotoxicity is defined by reduced left ventricular ejection fraction or new abnormal global longitudinal strain. — PERSEVERE: longitudinal assessment of quality of life and treatment toxicities in Chinese breast cancer patients – a multicentre cohort study protocol
- Reported toxicities include pain, lymphoedema, fatigue, anxiety, depression, sleep disturbance, cognitive change, and cardiotoxicity. — PERSEVERE: longitudinal assessment of quality of life and treatment toxicities in Chinese breast cancer patients – a multicentre cohort study protocol
- Breast cancer treatments can cause acute and chronic adverse effects affecting recovery and everyday function. — PERSEVERE: longitudinal assessment of quality of life and treatment toxicities in Chinese breast cancer patients – a multicentre cohort study protocol
- Cancer-related fatigue can persist for years after treatment. — PERSEVERE: longitudinal assessment of quality of life and treatment toxicities in Chinese breast cancer patients – a multicentre cohort study protocol